Variant report
Variant | esv3322828 |
---|---|
Chromosome Location | chr11:71910304-71914502 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:71912622..71915956-chr11:71917923..71921689,3 | K562 | blood: | |
2 | chr11:71913109..71914798-chr11:71920189..71923026,2 | K562 | blood: | |
3 | chr11:71911826..71915814-chr11:71931588..71936470,5 | MCF-7 | breast: | |
4 | chr11:71820511..71822627-chr11:71909286..71911348,2 | MCF-7 | breast: | |
5 | chr11:71911722..71914481-chr11:71934038..71936819,2 | MCF-7 | breast: | |
6 | chr11:71738692..71740500-chr11:71910713..71912758,2 | K562 | blood: | |
7 | chr11:71843841..71846091-chr11:71912939..71915274,2 | MCF-7 | breast: | |
8 | chr11:71830114..71831813-chr11:71912584..71915054,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000204971 | chromatin interactions |
ENSG00000110200 | chromatin interactions |
ENSG00000165458 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544105772 | chr11:71910310-71910311 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs11235463 | chr11:71910316-71910317 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs529658947 | chr11:71910328-71910329 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs182343678 | chr11:71910346-71910347 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs116331024 | chr11:71910369-71910370 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs571860381 | chr11:71910374-71910375 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs527364915 | chr11:71910384-71910385 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs139086156 | chr11:71910389-71910390 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs74383603 | chr11:71910415-71910416 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs564233053 | chr11:71910426-71910427 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs563559130 | chr11:71910447-71910448 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs539194807 | chr11:71910474-71910475 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs11235464 | chr11:71910478-71910479 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs186914241 | chr11:71910503-71910504 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs557273965 | chr11:71910537-71910538 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs554931597 | chr11:71910617-71910618 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs573294519 | chr11:71910618-71910619 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs540720719 | chr11:71910661-71910662 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs558737585 | chr11:71910664-71910665 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs576638465 | chr11:71910674-71910675 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs543970640 | chr11:71910758-71910759 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs66484462 | chr11:71910784-71910785 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs184334438 | chr11:71910816-71910817 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs541495535 | chr11:71910870-71910871 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs560084277 | chr11:71910881-71910882 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs117893789 | chr11:71910897-71910898 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs552258207 | chr11:71910905-71910906 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs373586133 | chr11:71910931-71910932 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs35030411 | chr11:71910932-71910933 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs149542601 | chr11:71910974-71910975 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs146212719 | chr11:71910975-71910976 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs567801616 | chr11:71910976-71910977 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs189808032 | chr11:71910991-71910992 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs532775035 | chr11:71911047-71911048 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs559686970 | chr11:71911052-71911053 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs551170936 | chr11:71911063-71911064 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs569603927 | chr11:71911065-71911066 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs192918628 | chr11:71911123-71911124 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs185090581 | chr11:71911176-71911177 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs190477287 | chr11:71911234-71911235 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs533904301 | chr11:71911277-71911278 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs181777950 | chr11:71911358-71911359 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs57538528 | chr11:71911359-71911360 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576901034 | chr11:71911393-71911394 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs55912327 | chr11:71911397-71911398 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs369918257 | chr11:71911400-71911401 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs141288580 | chr11:71911423-71911424 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs555925938 | chr11:71911444-71911445 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs186196835 | chr11:71911476-71911477 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs150347061 | chr11:71911513-71911514 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chordoma | 21602918 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 21806811 | CNVD |
Breast cancer | 22002566 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20953835 | CNVD |
oto-dental syndrome | 17656375 | CNVD |
Asthma | 21956041 | CNVD |
Breast cancer | 17603634 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17001317 | CNVD |
Oral squamous cell carcinoma | 16619035 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668395 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Neonatal seizures | 17668395 | CNVD |
Neonatal seizures | 17668391 | CNVD |
Neuroticism | 17667963 | CNVD |
Cancer | 17916600 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Multiple endocrine neoplasia type 1 | 19566914 | CNVD |
XY sex reversal | 17503084 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668391 | CNVD |
Maculopathy | 17646752 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Neuroblastoma | 18923191 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Leukoplakia | 24403051 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 22429812 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:71906200-71912200 | Enhancers | Placenta | Placenta |
2 | chr11:71907400-71911200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
3 | chr11:71909800-71910600 | Enhancers | Hela-S3 | cervix |
4 | chr11:71909800-71910600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
5 | chr11:71909800-71911000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
6 | chr11:71910000-71911000 | Enhancers | Primary monocytes fromperipheralblood | blood |
7 | chr11:71910200-71910800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
8 | chr11:71910400-71910800 | Enhancers | HepG2 | liver |
9 | chr11:71910600-71914000 | Weak transcription | Hela-S3 | cervix |
10 | chr11:71910600-71915200 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
11 | chr11:71911000-71914000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
12 | chr11:71914000-71914200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
13 | chr11:71914000-71914400 | Enhancers | Hela-S3 | cervix |
14 | chr11:71914000-71920800 | Enhancers | Primary monocytes fromperipheralblood | blood |
15 | chr11:71914200-71914600 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |
16 | chr11:71914400-71915800 | Weak transcription | Hela-S3 | cervix |